Predictability and identifiability assessment of models for prostate cancer under androgen suppression therapy

Zhimin Wu, Tin Phan, Javier Baez, Yang Kuang, Eric Kostelich

Research output: Contribution to journalArticle

Abstract

The past two decades have seen the development of numerous mathematical models to study various aspects of prostate cancer in clinical settings. These models often contain large sets of parameters and rely on limited data sets for validation. The quantitative analysis of the dynamics of prostate cancer under treatment may be hindered by the lack of identifiability of the parameters from the available data, which limits the predictive ability of the model. Using three ordinary differential equation models as case studies, we carry out a numerical investigation of the identifiability and uncertainty quantification of the model parameters. In most cases, the parameters are not identifiable from time series of prostate-specific antigen, which is used as a clinical proxy for tumor progression. It may not be possible to define a finite confidence bound on an unidentifiable parameter, and the relative uncertainties in even identifiable parameters may be large in some cases. The Fisher information matrix may be used to determine identifiable parameter subsets for a given model. The use of biological constraints and additional types of measurements, should they become available, may reduce these uncertainties. Ensemble Kalman filtering may provide clinically useful, short-term predictions of patient outcomes from imperfect models, though care must be taken when estimating “patient-specific” parameters. Our results demonstrate the importance of parameter identifiability in the validation and predictive ability of mathematical models of prostate tumor treatment. Observing-system simulation experiments, widely used in meteorology, may prove useful in the development of biomathematical models intended for future clinical application.

Original languageEnglish (US)
Pages (from-to)3512-3536
Number of pages25
JournalMathematical Biosciences and Engineering
Volume16
Issue number5
DOIs
StatePublished - Jan 1 2019

Fingerprint

Prostate Cancer
Identifiability
prostatic neoplasms
Predictability
androgens
Androgens
Therapy
Uncertainty
Prostatic Neoplasms
therapeutics
Theoretical Models
Meteorology
Proxy
Prostate-Specific Antigen
Prostate
Neoplasms
mathematical models
Therapeutics
uncertainty
Tumors

Keywords

  • Androgen suppression
  • Ensemble Kalman filter
  • Mathematical modeling
  • Parameter estimation
  • Parameter identifiability
  • Prostate cancer
  • Uncertainty quantification

ASJC Scopus subject areas

  • Modeling and Simulation
  • Agricultural and Biological Sciences(all)
  • Computational Mathematics
  • Applied Mathematics

Cite this

Predictability and identifiability assessment of models for prostate cancer under androgen suppression therapy. / Wu, Zhimin; Phan, Tin; Baez, Javier; Kuang, Yang; Kostelich, Eric.

In: Mathematical Biosciences and Engineering, Vol. 16, No. 5, 01.01.2019, p. 3512-3536.

Research output: Contribution to journalArticle

@article{474d8306534e4b588e8fb1f39059bba9,
title = "Predictability and identifiability assessment of models for prostate cancer under androgen suppression therapy",
abstract = "The past two decades have seen the development of numerous mathematical models to study various aspects of prostate cancer in clinical settings. These models often contain large sets of parameters and rely on limited data sets for validation. The quantitative analysis of the dynamics of prostate cancer under treatment may be hindered by the lack of identifiability of the parameters from the available data, which limits the predictive ability of the model. Using three ordinary differential equation models as case studies, we carry out a numerical investigation of the identifiability and uncertainty quantification of the model parameters. In most cases, the parameters are not identifiable from time series of prostate-specific antigen, which is used as a clinical proxy for tumor progression. It may not be possible to define a finite confidence bound on an unidentifiable parameter, and the relative uncertainties in even identifiable parameters may be large in some cases. The Fisher information matrix may be used to determine identifiable parameter subsets for a given model. The use of biological constraints and additional types of measurements, should they become available, may reduce these uncertainties. Ensemble Kalman filtering may provide clinically useful, short-term predictions of patient outcomes from imperfect models, though care must be taken when estimating “patient-specific” parameters. Our results demonstrate the importance of parameter identifiability in the validation and predictive ability of mathematical models of prostate tumor treatment. Observing-system simulation experiments, widely used in meteorology, may prove useful in the development of biomathematical models intended for future clinical application.",
keywords = "Androgen suppression, Ensemble Kalman filter, Mathematical modeling, Parameter estimation, Parameter identifiability, Prostate cancer, Uncertainty quantification",
author = "Zhimin Wu and Tin Phan and Javier Baez and Yang Kuang and Eric Kostelich",
year = "2019",
month = "1",
day = "1",
doi = "10.3934/mbe.2019176",
language = "English (US)",
volume = "16",
pages = "3512--3536",
journal = "Mathematical Biosciences and Engineering",
issn = "1547-1063",
publisher = "Arizona State University",
number = "5",

}

TY - JOUR

T1 - Predictability and identifiability assessment of models for prostate cancer under androgen suppression therapy

AU - Wu, Zhimin

AU - Phan, Tin

AU - Baez, Javier

AU - Kuang, Yang

AU - Kostelich, Eric

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The past two decades have seen the development of numerous mathematical models to study various aspects of prostate cancer in clinical settings. These models often contain large sets of parameters and rely on limited data sets for validation. The quantitative analysis of the dynamics of prostate cancer under treatment may be hindered by the lack of identifiability of the parameters from the available data, which limits the predictive ability of the model. Using three ordinary differential equation models as case studies, we carry out a numerical investigation of the identifiability and uncertainty quantification of the model parameters. In most cases, the parameters are not identifiable from time series of prostate-specific antigen, which is used as a clinical proxy for tumor progression. It may not be possible to define a finite confidence bound on an unidentifiable parameter, and the relative uncertainties in even identifiable parameters may be large in some cases. The Fisher information matrix may be used to determine identifiable parameter subsets for a given model. The use of biological constraints and additional types of measurements, should they become available, may reduce these uncertainties. Ensemble Kalman filtering may provide clinically useful, short-term predictions of patient outcomes from imperfect models, though care must be taken when estimating “patient-specific” parameters. Our results demonstrate the importance of parameter identifiability in the validation and predictive ability of mathematical models of prostate tumor treatment. Observing-system simulation experiments, widely used in meteorology, may prove useful in the development of biomathematical models intended for future clinical application.

AB - The past two decades have seen the development of numerous mathematical models to study various aspects of prostate cancer in clinical settings. These models often contain large sets of parameters and rely on limited data sets for validation. The quantitative analysis of the dynamics of prostate cancer under treatment may be hindered by the lack of identifiability of the parameters from the available data, which limits the predictive ability of the model. Using three ordinary differential equation models as case studies, we carry out a numerical investigation of the identifiability and uncertainty quantification of the model parameters. In most cases, the parameters are not identifiable from time series of prostate-specific antigen, which is used as a clinical proxy for tumor progression. It may not be possible to define a finite confidence bound on an unidentifiable parameter, and the relative uncertainties in even identifiable parameters may be large in some cases. The Fisher information matrix may be used to determine identifiable parameter subsets for a given model. The use of biological constraints and additional types of measurements, should they become available, may reduce these uncertainties. Ensemble Kalman filtering may provide clinically useful, short-term predictions of patient outcomes from imperfect models, though care must be taken when estimating “patient-specific” parameters. Our results demonstrate the importance of parameter identifiability in the validation and predictive ability of mathematical models of prostate tumor treatment. Observing-system simulation experiments, widely used in meteorology, may prove useful in the development of biomathematical models intended for future clinical application.

KW - Androgen suppression

KW - Ensemble Kalman filter

KW - Mathematical modeling

KW - Parameter estimation

KW - Parameter identifiability

KW - Prostate cancer

KW - Uncertainty quantification

UR - http://www.scopus.com/inward/record.url?scp=85064935975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064935975&partnerID=8YFLogxK

U2 - 10.3934/mbe.2019176

DO - 10.3934/mbe.2019176

M3 - Article

VL - 16

SP - 3512

EP - 3536

JO - Mathematical Biosciences and Engineering

JF - Mathematical Biosciences and Engineering

SN - 1547-1063

IS - 5

ER -